Researchers have developed an innovative dual-receptor T-cell therapy that promises safer and more effective cancer ...

From connectors and containers to plasmids and platforms, companies work to get these treatments to patients faster and more ...

A key enzyme and its molecular pathway are critical to keeping certain immune cells active and away from "exhaustion," ...

A study published in the journal Cell marks the first reported instance of generative AI designing synthetic molecules that ...

WEHI scientists have uncovered a promising new way to enhance the effectiveness of vaccines by tapping into the potential of a specific type of immune cell, opening the door to long-lasting vaccines ...

The ECOnti project's aim is to fit the entire manufacturing site into a small footprint as part of bioproduction democratization.

From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...

The new 450 Wh/kg SiCore™ battery offers unmatched energy density with production-scale availability for aviation and electric mobility platforms. New 450 Wh/kg SiCore™ battery offers ...

A recently developed cancer treatment called chimeric antigen receptor T-cell therapy (CAR T-cell therapy, for short) offers hope to people whose diffuse large B-cell lymphoma (DLBCL) has proved ...

In the present study, the modified HSV-ΔICP34.5-based constructs effectively reactivated HIV/SIV latency by modulating the IKKα/β-NF-κB pathway and PP1-HSF1 pathway (Shock) and simultaneously elicited ...

Toyo Co. has started production at its 2 GW solar cell facility in Ethiopia, with plans to deliver more than 80 MW of tunnel oxide passivated contact (TOPCon) cells by the end of April before ...

has officially started production at its new facility in Ethiopia in early April 2025. The company is scheduled to deliver more than 80 MW of solar cells to customers by the end of April.